| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 7.24e-05 | 28 | 58 | 3 | GO:0005242 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 2.33e-05 | 3 | 58 | 2 | GO:0071691 | |
| GeneOntologyCellularComponent | Z disc | 6.19e-05 | 151 | 58 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 9.70e-05 | 166 | 58 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.50e-04 | 290 | 58 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 6.31e-04 | 249 | 58 | 5 | GO:0030017 | |
| Domain | K_chnl_inward-rec_Kir_N | 2.84e-08 | 3 | 58 | 3 | IPR013673 | |
| Domain | IRK_N | 2.84e-08 | 3 | 58 | 3 | PF08466 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 9.48e-06 | 2 | 58 | 2 | IPR003272 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 1.55e-05 | 16 | 58 | 3 | IPR013518 | |
| Domain | IRK | 1.55e-05 | 16 | 58 | 3 | PF01007 | |
| Domain | - | 1.55e-05 | 16 | 58 | 3 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 1.55e-05 | 16 | 58 | 3 | IPR016449 | |
| Domain | NEBU | 5.66e-05 | 4 | 58 | 2 | SM00227 | |
| Domain | Nebulin | 5.66e-05 | 4 | 58 | 2 | PF00880 | |
| Domain | Nebulin | 5.66e-05 | 4 | 58 | 2 | IPR013998 | |
| Domain | NEBULIN | 5.66e-05 | 4 | 58 | 2 | PS51216 | |
| Domain | Nebulin_repeat | 5.66e-05 | 4 | 58 | 2 | IPR000900 | |
| Domain | Interfer-bind | 4.20e-04 | 10 | 58 | 2 | PF09294 | |
| Domain | Interferon/interleukin_rcp_dom | 4.20e-04 | 10 | 58 | 2 | IPR015373 | |
| Domain | Tissue_fac | 6.13e-04 | 12 | 58 | 2 | PF01108 | |
| Domain | Tissue_factor | 6.13e-04 | 12 | 58 | 2 | IPR001187 | |
| Domain | ATPase_dyneun-rel_AAA | 8.42e-04 | 14 | 58 | 2 | IPR011704 | |
| Domain | AAA_5 | 8.42e-04 | 14 | 58 | 2 | PF07728 | |
| Domain | - | 2.04e-03 | 746 | 58 | 8 | 3.40.50.300 | |
| Domain | Pept_cys_AS | 3.40e-03 | 28 | 58 | 2 | IPR000169 | |
| Domain | Ig_E-set | 4.14e-03 | 104 | 58 | 3 | IPR014756 | |
| Domain | P-loop_NTPase | 4.48e-03 | 848 | 58 | 8 | IPR027417 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 3.46e-05 | 19 | 48 | 3 | MM15194 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 17640933 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 11410627 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 10904001 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 20798526 | ||
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 7580148 | ||
| Pubmed | Functional consequences of Kir2.1/Kir2.2 subunit heteromerization. | 2.73e-06 | 2 | 58 | 2 | 20676672 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 20921230 | ||
| Pubmed | Dual-mode phospholipid regulation of human inward rectifying potassium channels. | 2.73e-06 | 2 | 58 | 2 | 21281576 | |
| Pubmed | Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery. | 2.73e-06 | 2 | 58 | 2 | 12598232 | |
| Pubmed | Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. | 2.73e-06 | 2 | 58 | 2 | 19926456 | |
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 2.73e-06 | 2 | 58 | 2 | 15705530 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 26520451 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 25885757 | ||
| Pubmed | PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. | 3.53e-06 | 18 | 58 | 3 | 21511879 | |
| Pubmed | WDR19 NEO1 OXA1L MDN1 SUPT6H SLC20A1 DDX18 PIK3R3 ASNS CHD1 ADI1 PIBF1 | 5.13e-06 | 1487 | 58 | 12 | 33957083 | |
| Pubmed | 6.22e-06 | 71 | 58 | 4 | 23400010 | ||
| Pubmed | Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1. | 8.19e-06 | 3 | 58 | 2 | 16258766 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26786162 | ||
| Pubmed | Differential polyamine sensitivity in inwardly rectifying Kir2 potassium channels. | 8.19e-06 | 3 | 58 | 2 | 16373386 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32776921 | ||
| Pubmed | Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. | 8.19e-06 | 3 | 58 | 2 | 12032359 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 8083233 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8921409 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 32990585 | ||
| Pubmed | Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. | 1.64e-05 | 4 | 58 | 2 | 15958527 | |
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 1.91e-05 | 31 | 58 | 3 | 17473172 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 31883643 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 16177047 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 32541000 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 29326130 | ||
| Pubmed | Inward rectifier potassium channel Kir2.2 is associated with synapse-associated protein SAP97. | 2.72e-05 | 5 | 58 | 2 | 11181181 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9529344 | ||
| Pubmed | Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy. | 4.08e-05 | 6 | 58 | 2 | 30986853 | |
| Pubmed | Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. | 7.60e-05 | 8 | 58 | 2 | 27930290 | |
| Pubmed | 1.08e-04 | 453 | 58 | 6 | 29656893 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 14960569 | ||
| Pubmed | MDN1 IQGAP2 KRT19 PPP1R12A APOB RIMS1 KAT2A NEB DNAH8 ERLIN1 | 1.24e-04 | 1442 | 58 | 10 | 35575683 | |
| Pubmed | Salivary protein profiles are linked to bitter taste acceptance in infants. | 1.49e-04 | 11 | 58 | 2 | 24248522 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 10049592 | ||
| Pubmed | Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha). | 2.11e-04 | 13 | 58 | 2 | 9494081 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 35260907 | ||
| Pubmed | 2.68e-04 | 1014 | 58 | 8 | 32416067 | ||
| Pubmed | 2.74e-04 | 187 | 58 | 4 | 26460568 | ||
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 16382105 | ||
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 14746139 | ||
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 3.23e-04 | 16 | 58 | 2 | 24960163 | |
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 15024025 | ||
| Pubmed | Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression. | 4.59e-04 | 19 | 58 | 2 | 36359803 | |
| Pubmed | 4.80e-04 | 217 | 58 | 4 | 30619736 | ||
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 15967462 | ||
| Pubmed | 5.23e-04 | 222 | 58 | 4 | 37071664 | ||
| Pubmed | Loss of the PlagL2 transcription factor affects lacteal uptake of chylomicrons. | 6.18e-04 | 22 | 58 | 2 | 17983586 | |
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.18e-04 | 22 | 58 | 2 | 18391953 | |
| Pubmed | 6.37e-04 | 234 | 58 | 4 | 36243803 | ||
| Pubmed | 6.71e-04 | 638 | 58 | 6 | 31182584 | ||
| Pubmed | 6.76e-04 | 23 | 58 | 2 | 19841136 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 7.63e-04 | 431 | 58 | 5 | 33660365 | |
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 17185339 | ||
| Pubmed | 8.00e-04 | 25 | 58 | 2 | 36343752 | ||
| Pubmed | 8.66e-04 | 26 | 58 | 2 | 9226367 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 9.34e-04 | 27 | 58 | 2 | 18649358 | |
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 17273973 | ||
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 9.34e-04 | 27 | 58 | 2 | 18468998 | |
| Pubmed | 1.00e-03 | 28 | 58 | 2 | 20689807 | ||
| Pubmed | 1.15e-03 | 30 | 58 | 2 | 16420439 | ||
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | 1.27e-03 | 483 | 58 | 5 | 27107014 | |
| Pubmed | 1.31e-03 | 32 | 58 | 2 | 26142281 | ||
| Pubmed | 1.33e-03 | 129 | 58 | 3 | 23022380 | ||
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 1.40e-03 | 33 | 58 | 2 | 8672127 | |
| Pubmed | 1.42e-03 | 496 | 58 | 5 | 31343991 | ||
| Pubmed | 1.44e-03 | 497 | 58 | 5 | 23414517 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.53e-03 | 1024 | 58 | 7 | 24711643 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 6.39e-06 | 16 | 42 | 3 | 276 | |
| CoexpressionAtlas | parathyroid gland | 4.41e-06 | 347 | 58 | 8 | parathyroid gland | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-06 | 194 | 58 | 5 | 40251e6415a62fa55d86f2e8609bf0402e1c1abb | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-05 | 133 | 58 | 4 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.05e-05 | 163 | 58 | 4 | 22fa5d017ff796394394d952ec151e2d1beb8248 | |
| ToppCell | C_02|World / shred on cell type and cluster | 6.34e-05 | 165 | 58 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 168 | 58 | 4 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-05 | 168 | 58 | 4 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 7.45e-05 | 172 | 58 | 4 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.79e-05 | 174 | 58 | 4 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.79e-05 | 174 | 58 | 4 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 69f68eeab11b088fcb1f963c92eff0f1cd0e711a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.07e-05 | 181 | 58 | 4 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 184 | 58 | 4 | c2ca984551baf4becbefbe58bd1889828542b045 | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 186 | 58 | 4 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 188 | 58 | 4 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 191 | 58 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 192 | 58 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 193 | 58 | 4 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-04 | 193 | 58 | 4 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 193 | 58 | 4 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 196 | 58 | 4 | 2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 196 | 58 | 4 | d9426eba69047166ffa8179f1654e011c1020328 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 196 | 58 | 4 | 8e909c31733762646359fe78b645cbd60237459e | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 196 | 58 | 4 | 7e19919eafd6ddf547dd4e8aa532a050e182c5cc | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-04 | 196 | 58 | 4 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | suprabasal_cell|World / shred by cell class for bronchial biopsy | 1.23e-04 | 196 | 58 | 4 | 3c1fa7ec1c7e02b45b2c5843d2c5b2063cd13be8 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 1.26e-04 | 197 | 58 | 4 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.26e-04 | 197 | 58 | 4 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 198 | 58 | 4 | 686d973483d027a3ffa2ad4430ba6e50f3d1378e | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.28e-04 | 198 | 58 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 198 | 58 | 4 | a76366611f3561fc8aca7d62d1f0a0ea2bef7792 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-04 | 199 | 58 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-04 | 199 | 58 | 4 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 58 | 4 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 58 | 4 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 58 | 4 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| Computational | Neighborhood of PHB | 7.24e-05 | 125 | 38 | 5 | MORF_PHB | |
| Disease | protein-tyrosine kinase 2-beta measurement | 2.12e-05 | 4 | 56 | 2 | EFO_0801969 | |
| Disease | probable ATP-dependent RNA helicase DDX58 measurement | 2.12e-05 | 4 | 56 | 2 | EFO_0801913 | |
| Disease | fructose-1,6-bisphosphatase 1 measurement | 5.28e-05 | 6 | 56 | 2 | EFO_0801606 | |
| Disease | trimethyllysine measurement | 1.92e-04 | 11 | 56 | 2 | EFO_0009134 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.97e-04 | 68 | 56 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | amenorrhea, response to antineoplastic agent | 3.66e-04 | 15 | 56 | 2 | EFO_0010269, GO_0097327 | |
| Disease | phosphatidylinositol measurement | 7.92e-04 | 95 | 56 | 3 | EFO_0010230 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 9.51e-04 | 24 | 56 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | Ciliopathies | 1.21e-03 | 110 | 56 | 3 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTKEGYYYRQVFERH | 511 | P08243 | |
| DAEYYAAHKYATSNK | 261 | O75477 | |
| KTHGSEYYECSRYKE | 331 | O95376 | |
| EIHIVHYNSKYKSYD | 136 | P23280 | |
| HYNSKYKSYDIAQDA | 141 | P23280 | |
| YKQDSRYYSDREKHR | 1591 | O14646 | |
| EKAYVEFQDYITKTY | 526 | P13056 | |
| VHKEEDTDTKQVYFY | 186 | Q92830 | |
| FEEKHYYKVDYSRFH | 331 | P63252 | |
| DYHQEAYKESYKDRR | 116 | Q9UH92 | |
| FQHKDSYIEYKRADS | 1136 | Q6IE37 | |
| DYSHYYTTIQDLRDK | 126 | P08727 | |
| YEDKYYKEVQTVSEH | 2766 | Q9NU22 | |
| NQYKIDYSHFHKTYE | 336 | Q14500 | |
| NVAYKADYKHDIVDY | 441 | Q86VF7 | |
| ANDRENYDIIKTYHY | 261 | Q9UK73 | |
| YAKYFDAATTEYVQK | 216 | O00757 | |
| YADYEESRMKYEKVH | 346 | Q12996 | |
| YYVAELDATKKLYHS | 486 | Q96JB1 | |
| KKSYEMNGREYHYVS | 466 | Q96JB8 | |
| SDAHRKAYEIYHESY | 196 | P09848 | |
| HARVYHTYDEKYRQE | 1101 | P09848 | |
| RYQKEKNVSIEDYYE | 186 | Q969J5 | |
| DHIEYYKASSEMALY | 191 | Q15070 | |
| HKSAQEAYKSYIRAY | 576 | Q9NVP1 | |
| TSDYEHQYYAKVKAI | 101 | Q9UHF4 | |
| REQYSKYNIHKDQYR | 1316 | Q86UR5 | |
| YYRRKDHKVGYETFS | 316 | Q86UW1 | |
| SQYQEKSKEYDRLYE | 186 | Q92569 | |
| FKHLRKYTYNYEAES | 46 | P04114 | |
| DYHKQLSEIEKYYAT | 156 | Q6ZRK6 | |
| EKYSNRLYKYDHNFV | 161 | P53634 | |
| AISEYNKATKDDYYR | 51 | P01037 | |
| NKHPVAEYKEYYESR | 531 | Q8IYK4 | |
| YQYHTVHKDSGLYKE | 376 | Q8WUM9 | |
| YHTDILKEKYRGQYD | 261 | Q8N5C7 | |
| DHSKAHYYRYDEQLN | 156 | Q9BSM1 | |
| NQYKIDYSHFHKTYE | 336 | B7U540 | |
| TEEAAKYREKIYYFS | 951 | Q5TCS8 | |
| LYETQRKYHSAKEAY | 211 | O14607 | |
| RYYVINECDSYKKKH | 886 | Q7Z5M5 | |
| LKEKTHTQHYECYRY | 296 | Q6ZU15 | |
| HKKYDYYYNTDSKES | 606 | Q13576 | |
| KYTEYSFRVVAYNKH | 601 | Q92859 | |
| HAQTIKVDYKQRYYT | 781 | Q92859 | |
| YDDDKVYTYVFHKDT | 576 | Q8NEZ3 | |
| MSHKQIYYSDKYDDE | 1 | P61024 | |
| KDVDEAHYAYSFKYL | 626 | Q7KZ85 | |
| KYIVHKEFDDDTYDN | 391 | P00750 | |
| LNHEYKKYLDAEQSY | 416 | Q96DM3 | |
| RENSYSYNKYDKDLS | 291 | Q14586 | |
| EEMYEKYVASRDHYK | 356 | Q8WXW3 | |
| KYVASRDHYKTEYEN | 361 | Q8WXW3 | |
| DKIVHYLVENSSKYY | 141 | Q2NKQ1 | |
| QEQYYSEKYQKREHI | 1021 | Q9NQ66 | |
| EHRSYEYHKYGEKSY | 126 | Q8N972 | |
| RKKNNHSERKYYYYE | 751 | Q9NS56 | |
| SQYFEKFDVKESSYH | 311 | Q6BDS2 | |
| KFHLSYTDKERYENE | 86 | Q96MV8 | |
| ERFAKQYRDHYDKLY | 2016 | Q15911 | |
| IYHRFTVDEKNYTKA | 131 | Q9BV57 | |
| SEAERKEYFYKYFHN | 366 | P59046 | |
| EDEYKQKYSRTYDET | 751 | O14974 | |
| SRDIASDYKYKEAYR | 3271 | P20929 | |
| ASRDIASDYKYKEAY | 3756 | P20929 |